about
Modular alpha-helical mimetics with antiviral activity against respiratory syncitial virus.Identity by descent mapping of founder mutations in cancer using high-resolution tumor SNP data.Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutations.Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.TCF12 is mutated in anaplastic oligodendrogliomaExome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.Deciphering the molecular basis of invasiveness in Sdhb-deficient cells.Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling.Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.AAV2 and Hepatocellular Carcinoma.DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers.Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition.Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV.Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.Integrated genomic characterization of adrenocortical carcinoma.Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas.SDH mutations establish a hypermethylator phenotype in paraganglioma.DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication.Germline and somatic DICER1 mutations in familial and sporadic liver tumors.SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.[Mutations in succinate dehydrogenase and DNA methylation].Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesTransethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic SyndromeSDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paragangliomaSomatic NF1 inactivation is a frequent event in sporadic pheochromocytomaNon-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohortHypermethylator phenotype and ectopic GIP receptor in GNAS mutation-negative somatotropinomas
P50
Q31064129-18A99D85-AA70-417E-856E-3E1C69A3A659Q34261618-E9CC21A8-6B2D-4DBA-8385-E48AAC02829BQ34532927-C2A079DB-554B-4CA2-8CF5-26F3A11988BEQ35160825-4DB1DBF9-9336-4844-9C00-4B29A1C4C3FDQ35813648-74823920-B7DE-4B40-BB55-797F57F0553BQ36104399-9EAB275D-B5D1-4B64-92C7-9945F70C7CC1Q36545038-7B312F42-463B-420A-8CE4-7BD5D8F54771Q37284612-1CFF40F1-046E-4D11-816C-89FEFCA6A7F9Q38201985-A2FEEAE8-D475-4AF9-881F-67CD7950DC59Q38240032-8B70A056-08BF-4DF9-9DD7-A8292C4DB86BQ38770158-F0232857-6838-4EDC-8DDC-C2C342A031E4Q38976788-D135778A-80F4-4B41-80AF-3FEC7EC732B0Q39003817-D6F24545-A575-4DA1-BB87-497B3A4B0726Q39113102-50019377-4C09-4464-BB03-9447CF354723Q40613665-721A9457-72A7-4322-BE3D-064FE6AD6E3DQ40876157-0FCDEAF1-9365-418C-9751-5C831F1C55FEQ41137119-86F8E082-A3BE-4246-AB68-A9261F94C60DQ42654003-B0777834-C882-4A4F-9840-19C9AB284DA5Q42749767-347FC0B9-CF1A-4F64-8232-44750A79590FQ43287348-6682FDE9-FB87-4BA2-95F3-BE987324B6B5Q47151341-C445066F-7E33-44FA-8D40-BD8A1FF03036Q48153693-95999D34-C240-44E3-9B27-2572984A7D5FQ48305502-C42141CC-6C99-43FD-BBE9-B23F68AA82F0Q48315182-19B42AA0-85DA-4D23-B96E-07252FFC86A6Q50066568-110A2EF3-F84D-45FC-BB4E-F76E62250599Q50960567-3283F3CE-E5DC-4CE9-A510-37939E0E9BC3Q51499838-62AA3E65-CB6D-4D8D-A264-28113CD94E09Q52583832-5EE1F1F9-0CEB-44B1-A91B-2F7F4529719DQ52936606-A1012AE4-044F-49D9-8F21-666E80298B60Q53131280-A320756A-B72F-49A2-A1C6-BDC26F9A8DDCQ53272755-C9A2A19C-DC9A-4BE2-9CE3-EC68D3AE5086Q54415830-E2F36CBB-B518-4BAD-879A-B959226E89D1Q55337080-1AA71560-4E98-4346-A3B3-25090B109001Q55457407-5DDA970D-76BF-42E7-B85E-AA45F9C0CA5DQ56980682-EF36CD65-0C28-44C8-A5D3-DFF6612394D1Q57605578-72213337-516C-45CF-AF65-3CD3CD2D7199Q57817450-03DAFC4D-2860-4218-8431-8B2E1E7DADF9Q57817505-5BBBE28E-471F-4D80-A1DF-B19AB6E9904AQ58089525-A4583EA8-7D1D-4235-BA22-EFBF81B1E4DAQ58104040-271D03A8-3F1A-4BBC-9C9C-86765CBD3203
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Letouzé
@ast
Eric Letouzé
@en
Eric Letouzé
@es
Eric Letouzé
@nl
Eric Letouzé
@sl
type
label
Eric Letouzé
@ast
Eric Letouzé
@en
Eric Letouzé
@es
Eric Letouzé
@nl
Eric Letouzé
@sl
prefLabel
Eric Letouzé
@ast
Eric Letouzé
@en
Eric Letouzé
@es
Eric Letouzé
@nl
Eric Letouzé
@sl
P106
P31
P496
0000-0002-6369-2839